Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VOR
DateTimeSourceHeadlineSymbolCompany
28/12/202401:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
28/12/202401:00GlobeNewswire Inc.Vor Bio Announces $55.6 Million Private PlacementNASDAQ:VORVor Biopharma Inc
09/12/202423:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
09/12/202423:30GlobeNewswire Inc.Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial DesignNASDAQ:VORVor Biopharma Inc
15/11/202408:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VORVor Biopharma Inc
13/11/202400:00GlobeNewswire Inc.Vor Bio to Participate in the Stifel 2024 Healthcare ConferenceNASDAQ:VORVor Biopharma Inc
09/11/202408:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
09/11/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/11/202408:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
08/11/202408:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
06/11/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
06/11/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/10/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/10/202406:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
30/09/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
30/09/202421:00GlobeNewswire Inc.Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial OfficerNASDAQ:VORVor Biopharma Inc
06/09/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
06/09/202406:01GlobeNewswire Inc.New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:VORVor Biopharma Inc
05/09/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/09/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
31/08/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
28/08/202422:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
09/08/202406:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
09/08/202406:13Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:VORVor Biopharma Inc
09/08/202406:05GlobeNewswire Inc.Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
09/08/202406:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
06/08/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/08/202406:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
20/07/202407:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VORVor Biopharma Inc
10/07/202406:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:VOR